Available in United States, Argentina
Subjects will be randomized 1:1 to an experimental study group and a sham comparator
(control) group.
Subjects in the experimental group will receive four (4) IPL treatments and meibomian
gland expression (MGX) at 2-week intervals. IPL pulses will be administered on the skin
of the malar region and below the lower eyelids. Following IPL therapy, subjects will
undergo MGX of both eyelids in both eyes. Subjects in the control group will receive the
same treatment (IPL followed by MGX), except that the IPL administration will be
performed with the device off (sham treatment). Follow-up visits will occur at 1 month
and 3 months after the final treatment session. At the follow-up, the changes in the
outcome measures will be evaluated and compared between the two groups.
1Research sites
100Patients around the world